Stock Fundamentals

Company Information

Company Name
Stevanato Group SpA
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NYSE
ISIN: IT0005452658
CIK: 0001849853
Currency: USD
Full Time Employees: 6,010
Phone: 39 04 99 31 811
Fiscal Year End: December
IPO Date: Jul 16, 2021
Description:

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Address:

Via Molinella 17, Piombino Dese, PD, Italy, 35017

Directors & Officers

Name Title Year Born
Mr. Franco Stevanato CEO & Executive Chairman 1973
Mr. Marco Dal Lago Chief Financial Officer 1973
Ms. Lisa Miles Chief Communications & Investor Relations Officer NA
Ms. Carla Costa Chief Human Resources Officer NA
Mr. Mauro Stocchi Chief Business Officer 1967
Mr. Michele Monico President of DDS & IVD Business Unit NA
Mr. Raffaele Pace President of Engineering Business Unit NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Conestoga Capital Advisors, LLC 8.49M Mar 31, 2026 3.11% $2.33 7.63%
Neuberger Berman Group LLC 4.48M Mar 31, 2026 1.64% $0.05 -6.52%
TimesSquare Capital Management, LLC 3.49M Mar 31, 2026 1.28% $0.81 -0.30%
T. Rowe Price Investment Management,Inc. 3.22M Mar 31, 2026 1.18% $0.03 -28.18%
BAMCO Inc 2.50M Mar 31, 2026 0.92% $0.10 24.91%
Artisan Partners Limited Partnership 2.29M Mar 31, 2026 0.84% $0.05 -2.54%
Morgan Stanley - Brokerage Accounts 1.32M Mar 31, 2026 0.48% $0.00 333.07%
Ranger Investment Management LP 1.27M Mar 31, 2026 0.47% $1.26 -0.58%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 1.05M Mar 31, 2026 0.38% $0.38 -13.90%
Amvescap Plc. 851.60K Mar 31, 2026 0.31% $0.00 -1.14%
Deutsche Bank AG 849.22K Mar 31, 2026 0.31% $0.00 -2.14%
Royce & Associates, LP 841.33K Mar 31, 2026 0.31% $0.11 70.65%
Nicholas Company Inc 744.23K Mar 31, 2026 0.27% $0.20 -0.13%
Riverbridge Partners LLC 673.15K Mar 31, 2026 0.25% $0.23 -5.87%
Mutual Of America Capital Management LLC 645.98K Mar 31, 2026 0.24% $0.10 -0.47%
Cooper Investors Pty Limited 640.23K Mar 31, 2026 0.23% $3.59 -7.91%
Qube Research & Technologies 612.94K Mar 31, 2026 0.22% $0.01 4,189.86%
Sands Capital Management, LLC 497.31K Mar 31, 2026 0.18% $0.03 0.87%
Point72 Asset Management, L.P. 491.41K Mar 31, 2026 0.18% $0.01 0.00%
Peregrine Capital Management,LLC 457.14K Mar 31, 2026 0.17% $0.23 -4.57%

Shares Statistics

Shares Outstanding: 49.71M
Shares Float: 48.95M
% Insiders: 158.50%
% Institutions: 9,651.90%
Short % Float: 2.06%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Conestoga Small Cap Investors 3.58M 1.31% ▼ 18.26% Apr 30, 2026
2 Neuberger Genesis Inv 2.56M 0.94% ▲ 11.72% Mar 31, 2026
3 Conestoga Small Cap Growth 2.07M 0.76% ▲ 20.07% Mar 31, 2026
4 Baron Discovery Strategy 1.68M 0.62% ▲ 31.22% Mar 31, 2026
5 Baron Discovery Institutional 1.68M 0.62% ▲ 31.22% Mar 31, 2026
6 T. Rowe Price US Small-Cap Core Equity 1.31M 0.48% ▲ 10.74% Mar 31, 2026
7 Ranger Small Cap 1.27M 0.47% ▼ 0.58% Mar 31, 2026
8 Artisan U.S. Small-Cap Growth 856.12K 0.31% ▼ 6.01% Mar 31, 2026
9 Artisan Small Cap Investor 856.12K 0.31% ▼ 6.01% Mar 31, 2026
10 Conestoga SMid Cap Growth Composite 811.83K 0.30% ▲ 14.89% Mar 31, 2026

Valuation Metrics

Enterprise Value: $5.05B
Trailing P/E: 28.95
Forward P/E: 19.46

Financial Highlights

Market Cap: $4.66B
EBITDA: $288.58M
P/E Ratio: $28.95
PEG Ratio: $3.57
Book Value: $6.47
Dividend/Share: $0.00
Dividend Yield: 0.00%
Earnings/Share: $0.59
Profit Margin: 11.75%
Operating Margin: 14.24%
ROA (TTM): 5.27%
ROE (TTM): 9.59%
Revenue (TTM): $1.20B
Revenue/Share (TTM): $4.41
Earnings Growth (YOY): 2.90%
Revenue Growth (YOY): 6.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.74x 0.31x 0.42x 8.40x 1.59x
2024-12-31 1.84x 0.30x 0.40x 23.48x 1.68x
2023-12-31 1.50x 0.34x 0.45x 46.52x 1.41x
2022-12-31 1.83x 0.20x 0.40x 48.89x 0.79x
2021-12-31 2.56x 0.27x 0.41x 33.30x 1.00x
2020-12-31 1.56x 1.10x 0.68x 15.18x 2.19x
2019-12-31 1.71x 1.33x 0.70x 11.74x 3.33x
2018-12-31 1.62x 1.29x 0.70x N/A N/A

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about STVN.US!